Jürgen A. Bohnert - Concepedia

Author

Jürgen A. Bohnert

Also Known As

Bohnert, Jürgen, Bohnert, Jürgen A., J. A. Bohnert, J. Bohnert, J.A. Bohnert, Jürgen A. Bohnert, Jürgen A Bohnert, Jürgen A. Bohnert, Jürgen A. Bohnert (349932), Jürgen Bohnert

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Friedrich-Loeffler-Institut Universitätsmedizin Greifswald Universität Greifswald University Medical Center Freiburg University of Freiburg

About

Jürgen A. Bohnert is an author at Friedrich-Loeffler-Institut specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Health Sciences	5	5	312
3	Biochemistry	5	5	448
4	Natural Sciences	3	3	198
5	Engineering	1	1	21

Jürgen A. Bohnert

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop Thomas Eicher, Hi-jea Cha, Markus A. Seeger, Proceedings of the National Academy of Sciences	2012	339
Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study Christian Scheer, Christian Fuchs, Matthias Gründling, Clinical Microbiology and Infection Antibiotic AdministrationAntimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsBlood Culture Positivity	2018	266
Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in <i>Escherichia coli</i> Overexpressing RND Efflux Pumps Jürgen A. Bohnert, Winfried V. Kern Antimicrobial Agents and Chemotherapy Mdr ReversalAntimicrobial ChemotherapyPump-deficient Mutant StrainsAntibiotic ResistanceDrug Resistance	2005	221
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli Winfried V. Kern, Petra Steinke, Anja Schumacher, Journal of Antimicrobial Chemotherapy	2005	170
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide Stefanie Pannek, Paul G. Higgins, Petra Steinke, Journal of Antimicrobial Chemotherapy	2006	162
A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition Stefan E. Heiden, Nils‐Olaf Hübner, Jürgen A. Bohnert, Genome Medicine	2020	155
Optimized Nile Red Efflux Assay of AcrAB-TolC Multidrug Efflux System Shows Competition between Substrates Jürgen A. Bohnert, Brian A. Karamian, Hiroshi Nikaido Antimicrobial Agents and Chemotherapy	2010	152
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia Winfried V. Kern, KJ Klose, Angelika Jellen-Ritter, European Journal of Clinical Microbiology & Infectious Diseases Antimicrobial Resistance GeneHealth SciencesMedicineProphylactic Fluoroquinolone UseEscherichia Coli	2005	150
Site-Directed Mutagenesis Reveals Putative Substrate Binding Residues in the <i>Escherichia coli</i> RND Efflux Pump AcrB Jürgen A. Bohnert, Sabine Schuster, Markus A. Seeger, Journal of Bacteriology Protein FunctionProtein AssemblyBiochemistryNatural SciencesMolecular Biology	2008	130
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli Anja Schumacher, Petra Steinke, Jürgen A. Bohnert, Journal of Antimicrobial Chemotherapy	2005	122

Page 1